Frankfurt report: The European Union announced the approval of the listing of the new crown vaccine of the Omikon BA4 and BA5

China Well -off. September 10th. The Lao Malaysia EU Commission has approved another vaccine suitable for OMICRON. On Monday, EU Chairman Feng Bryin Ursula Von der Leyen announced on Twitter that the enhanced needle from Pfizer Biontech/PFIZER aims to fight the current new crown virus variant. An Expert Committee of EMA of the EU Drug Administration has previously suggested that it approves the vaccine that is applicable to the Omicron sub -variant BA.4/BA.5. Like the previous vaccine, the potion can also be targeted at SARS-COV-2 primitive strains. The German Federal Health Minister Carllatbach (SPD) rated the information on Twitter as a good news of the anti -virus.

EU Chairman Feng Brian

Frankfurt in Germany reported that Ema announced that it is expected to provide wider protection for different new coronal virus variants. It is recommended to vaccinate vaccines for people 12 and above as reinforcements. According to the data of random samples, BA.4/BA.5 is the Omitron infection that is currently infected with almost all new crown virus in Germany.

Due to the local nature of R & D, there is currently no complete clinical research on the BA.4/BA.5 vaccine. As explained by EMA, the expert committee considers all available data: for example, the recently approved vaccine approved in the European Union, the vaccine is aimed at Omitron Asian BA.1, which has clinical experimental data. A few days ago, this BA.1 vaccine began to be delivered in Germany.

- END -